Adenocarcinoma of the Rectum

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

The Utility and Feasibility of Mt-sDNA as a Surveillance Procedure in Colorectal Cancer Survivors

A Study of Response to Standard Treatment Before Surgery in People With Rectal Cancer

Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation

A Study of Tucatinib and Trastuzumab in People With Rectal Cancer

Short Course or Long Course Radiotherapy as Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer

MoLiMoR - A Study With FOLFIRI-based First-line Therapy With or Without Intermittent Cetuximab

Can We Save the Rectum by Watchful Waiting or TransAnal Surgery Following (chemo)Radiotherapy Versus Total Mesorectal Excision for Early REctal Cancer?

Concordance of Imaging and Pathology Diagnosis of Extranodal Tumour Deposits

Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal Cancer

Pembrolizumab In Combination With Debio 1143 In Pancreatic and Colorectal Advanced/Metastatic Adenocarcinoma

Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer

Non-Operative Radiation Management of Adenocarcinoma of the Lower Rectum

Study of Colorectal Cancer Patients (Stage IIIC) With Either Regorafenib or Standard of Care (No Treatment) After Adjuvant FOLFOX

AZD0530 (NSC 735464) in Treating Patients With Previously Treated Metastatic Colon Cancer or Rectal Cancer

Human Intestinal Microbiome and Surgical Outcomes in Patients Undergoing Colorectal Cancer Surgery

Midostaurin (PKC412) for Locally Advanced Rectal Cancer

Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks

Laparoscopy-Assisted Transanal Endoscopy Rectosigmoid Resection for Rectal Cancer

Bevacizumab, Erlotinib and 5-Fluorouracil With External Beam Radiation Therapy in Locally Advanced Rectal Cancer